Literature DB >> 7272172

Pharmacokinetics of cephradine given intravenously with and without probenecid.

D H Roberts, M J Kendall, D B Jack, P G Welling.   

Abstract

1 In the light of questions raised by an earlier oral study (Welling, Dean, Selen, Kendall & Wise, 1979) the influence of probenecid on the pharmacokinetics of intravenously administered cephradine has been investigated. 2 Intravenous administration of cephradine resulted in a bi-exponential curve and the level of antibiotic after 15 min was significantly greater when subjects received probenecid than when they did not. The influence of probenecid on urinary excretion of cephradine was similar to that observed previously. 3 The increase in serum of cephradine due to probenecid could be accounted for by the decrease in the elimination rate of the antibiotic. These results are discussed in the light of other observations.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7272172      PMCID: PMC1402198          DOI: 10.1111/j.1365-2125.1981.tb01171.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  On the mechanism of action of probenecid on renal tubular secretion.

Authors:  I M WEINER; J A WASHINGTON; G H MUDGE
Journal:  Bull Johns Hopkins Hosp       Date:  1960-06

Review 2.  Cephradine--a summary of preclinical studies and clinical pharmacology.

Authors:  E S Neiss
Journal:  J Ir Med Assoc       Date:  1973-03-24

3.  Influence of probenecid and food on the bioavailability of cephradine in normal male subjects.

Authors:  T W Mischler; A A Sugerman; D A Willard; L J Brannick; E S Neiss
Journal:  J Clin Pharmacol       Date:  1974 Nov-Dec       Impact factor: 3.126

4.  Apparent effect of probenecid on the distribution of penicillins in man.

Authors:  M Gibaldi; M A Schwartz
Journal:  Clin Pharmacol Ther       Date:  1968 May-Jun       Impact factor: 6.875

5.  The renal excretion of indomethacin and its inhibition by probenecid.

Authors:  M D Skeith; P A Simkin; L A Healey
Journal:  Clin Pharmacol Ther       Date:  1968 Jan-Feb       Impact factor: 6.875

6.  A new cephalosporin derivative, cephradine (TM) , in the treatment of acute infective diseases.

Authors:  B M Limson; R E Siasoco; F P Dial
Journal:  Curr Ther Res Clin Exp       Date:  1972-03

7.  The influence of a new benzoic acid derivative on the metabolism of paraaminosalicylic acid (PAS) and penicillin.

Authors:  W P BOGER; J O BEATTY; F W PITTS; H F FLIPPIN
Journal:  Ann Intern Med       Date:  1950-07       Impact factor: 25.391

8.  Probenecid: an unexplained effect on cephalosporin pharmacology.

Authors:  P G Welling; S Dean; A Selen; M J Kendall; R Wise
Journal:  Br J Clin Pharmacol       Date:  1979-11       Impact factor: 4.335

9.  Prolongation and enhancement of serum methotrexate concentrations by probenecid.

Authors:  G W Aherne; E Piall; V Marks; G Mould; W F White
Journal:  Br Med J       Date:  1978-04-29

10.  Pharmacologic studies with cefaclor, a new oral cephalosporin.

Authors:  B R Meyers; S Z Hirschman; G Wormser; G Gartenberg; E Srulevitch
Journal:  J Clin Pharmacol       Date:  1978-04       Impact factor: 3.126

View more
  1 in total

1.  The effect of induced fever on the biokinetics of norfloxacin and its interaction with probenecid in goats.

Authors:  K Jha; B K Roy; R C Singh
Journal:  Vet Res Commun       Date:  1996       Impact factor: 2.459

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.